CTIS2023-507489-20-00进行中（未招募）1 期
=1-studies In Statin-intolerance; Objectifying Nocebo Effects (NISONE)
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 249
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •1.Aged 18 years or older., 2.Previously taken two or more statins and withdrawn from statins because of (perceived) side effects., 3.Clinical indication for lipid lowering therapy related to secondary prevention of cardiovascular disease (previous CVD) or prevention of cardiovascular disease (both primary and secondary) in familial hypercholesterolemia., 4.Provided full informed consent.
排除标准
- •1.A contra-indication for rosuvastatin therapy related to: a.Previous statin use causing anaphylaxis or other moderate/severe allergic reaction. b.Previous statin use causing myopathy (serum rise of creatine kinase more than 3 times the upper limit of normal) or rhabdomyolysis. c.Previous statin use with liver function abnormalities, defined as aspartate aminotransferase (AST) or alanine aminotransferase >3 times the upper limit of normal. d.Previous statins use causing severe health issues. e.Planned pregnancy within 12 months, pregnancy or breastfeeding. f.Currently taking other drugs with known relevant interactions to rosuvastatin as listed in the Investigational Medicinal Product Dossier (IMPD). g.Any other contraindication for rosuvastatin as listed in the Investigational Medicinal Product Dossier (IMPD)., 2.History of myopathy or any other condition that causes severe chronic pain., 3.History of severe mental illness (as their experience of symptoms may already be altered)., 4.History of cirrhosis or severe renal insufficiency (eGFR < 20 ml/min/1,73m2), 5.Insufficient ability to fill in questionnaires in the digital platform; a.No access to a smartphone, tablet or personal computer. b.Insufficient understanding of the Dutch or English language., 6.Clinical judgement of the health care professional that LDLc-lowering therapy is not relevant for the prognosis (e.g. severe frailty, dementia, end-stage heart failure, end-stage malignancy)., 7.Clinical judgement of the health care professional who considers participation unethical or otherwise unwanted.
研究者
相似试验
招募中
3 期
Investigating the therapeutic effect of statin relative to the N-acetyl cysteine in the treatment of Helicobacter pylori patientsHelicobacter pylori patients.IRCT20231017059756N1Mashhad University of Medical Sciences180
终止
不适用
ow- and moderate-intensity Statin and Clinical Outcome of Primary prevention in individuals aged >75 years: the SCOPE-75 RCT StudyKCT0003629Yonsei University Health System, Severance Hospital2,484
招募中
不适用
ow- and moderate-intensity Statin and Clinical Outcome of Primary prevention in individuals aged >70 years: the SCOPE-70 RCT StudyKCT0004711Yonsei University Health System, Severance Hospital2,484
已完成
不适用
A prospective analysis of the effect of statins on postprandial serum triglyceride levelDyslipidemiaJPRN-UMIN000004156Suwa Central Hospital300
已完成
不适用
Treatment of Polycystic Ovary Syndrome in young single womePACTR201707002431613Minia University Obstetrics and Gynecology department200